Emma Aarnio
Biographic Data
| ID | 9571147 |
|---|---|
| NAME | Emma Aarnio |
| GIVEN NAMES | Emma |
| FAMILY NAME | Aarnio |
| SIGNATURE | AARNIO E |
| AFFILIATIONS | University of Eastern Finland |
| ORCID | 0000-0002-6555-7833 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes
A new reimbursement scheme for non-insulin medications used for treatment of hyperglycemia in type 2 diabetes (T2D) was implemented in Finland on January 1, 2017. The aim of the study was to evaluate the impact of this co-payment increase (i.e. + 35 percentage points) on patient-reported satisfaction for diabetes care, diabetes medication use, and financial difficulties. Baseline data were collected in 114 pharmacies, where patients with T2D were…
No prominent works on this page.
Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes
A new reimbursement scheme for non-insulin medications used for treatment of hyperglycemia in type 2 diabetes (T2D) was implemented in Finland on January 1, 2017. The aim of the study was to evaluate the impact of this co-payment increase (i.e. + 35 percentage points) on patient-reported satisfaction for diabetes care, diabetes medication use, and financial difficulties. Baseline data were collected in 114 pharmacies, where patients with T2D were…
Diabetes mellitus (1 work) · Diabetes Treatment and Management (1 work) · Endocrinology (1 work) · Family medicine (1 work) · Health care (1 work) · Insulin (1 work) · Internal Medicine (1 work) · Medication Adherence and Compliance (1 work) · Medicine (1 work) · Metformin (1 work)